News

San Diego-based Concerro has announced the launch of PanFluAware, an automated software solution and decision making system for H1N1 preparation and response. As the 2009/10 flu season begins,

Icagen has announced a one year extension to a prior collaboration and licensing agreement with Pfizer aimed at discovering, developing and commercializing compounds that modify three specific sodium

Abbott has released long-term data for the SPIRIT III pivotal US clinical trial, which demonstrated that the observed clinical advantages of XIENCE V Everolimus Eluting Coronary Stent System

Impax Laboratories has initiated a challenge of the patents listed by Galderma Laboratories, in connection with its ORACEA (doxycycline) delayed-release capsules, 40mg. Impax filed its Abbreviated New Drug

Amgen has announced detailed results from a phase 3 trial evaluating denosumab administered subcutaneously versus Zometa (zoledronic acid) administered as an intravenous infusion in the treatment of bone

Anavex Life Sciences has announced the completion of scale-up manufacturing of ANAVEX 2-73, its compound for the treatment of Alzheimer’s disease. Herve de Kergrohen, CEO of Anavex, said:

Galderma and Ipsen have announced that Azzalure (botulinum toxin type A manufactured by Ipsen), a local muscle relaxant specifically developed for aesthetic use, has received a marketing authorization

Glenmark Pharmaceuticals, a research-driven, global, integrated pharmaceutical, has said that it will raise INR12 billion. The company will raise the amount from overseas markets or by private placement

Varian has launched a suite of new products to enhance the flexibility and automated use of its 400-MR Nuclear Magnetic Resonance (NMR) system. The collection of new tools